Limited Evidence Supports Buprenorphine for Neonatal Abstinence Syndrome Limited Evidence Supports Buprenorphine for Neonatal Abstinence Syndrome

Buprenorphine might be the best pharmacological treatment for neonatal abstinence syndrome, based on limited evidence, according to a systematic review and network meta-analysis.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pediatrics News Source Type: news